Assessment of Cardiac Function Using Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing (CMR-CPET)

Pulmonary Hypertension Clinical Trial

— CMR-CPET  

Official title:

Assessment of Cardiac Function Using Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing (CMR-CPET)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04729777
• Other study ID #: 100358
• Secondary ID: 226101
• Status: Recruiting
• Start date: March 1, 2019
• Est. completion date: October 1, 2021

Study information

• Verified date: January 2021
• Source: Royal Free Hospital NHS Foundation Trust
• Contact: James Brown
• Phone: +44 (0)2074332780
• Email: james.brown1[@]nhs.net
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

What problems limit patients' response to exercise? Using exercise cardiac magnetic resonance imaging to assess the heart's response, with simultaneous measurement of respiratory oxygen and carbon dioxide levels to assess the lung and skeletal muscle responses, to identify the rate-limiting factors affecting different types of patient

Description:

Background and study aims Many medical conditions that affect the heart and lungs can cause breathlessness. People affected by breathlessness often require a number of tests to diagnose the medical condition responsible for their symptoms.

Cardiac MRI (magnetic resonance) scanning is already used to help diagnose and monitor patients with heart conditions (for example cardiomyopathy and pulmonary hypertension). By exercising while having an MRI scan, and at the same time measuring the gases breathed in and out from the air, it will be possible to more accurately understand the changes that occur in the heart, lungs and muscles.

The purpose of this study is to develop our understanding of the cardiovascular response to exercise in patients with non-ischaemic cardiomyopathy.

Who can participate? Patients aged 18 - 80 years with symptoms of breathlessness on exertion, and under the care of cardiology, pulmonary hypertension or rheumatology clinics for non-ischaemic cardiovascular disease.

What does the study involve? Participants will be invited to an appointment at the cardiovascular MRI department at the Royal Free Hospital. On the day of the appointment, participants will be welcomed to the department by the research team and the researchers will check that participants are well enough to exercise and safe to have an MRI scan. There will be an opportunity to ask any further questions.

The researchers will ask participants to perform exercise in one of three ways:

1. Using our special MRI safe exercise bike: The researchers will show participants how to use this and then the researchers will help participants to get on it and into the MRI scanner.

2. Lifting a weight using their arms: The researchers will check how much weight participants would be expected to manage before participants enter the scanner. The researchers will ask participants to lift and hold a weight using their dominant arm during the scan.

3. Stepping one (or both) leg(s) using an elastic resistance band. The researchers will measure the band so it is of the appropriate length for participants, and the researchers will show participants how to perform the exercise when in the scanner.

The researchers will give participants a special face mask to wear to measure the concentration of gases in exhaled breath (like carbon dioxide or oxygen) and breathing volumes. Most adults and children find the face mask comfortable and easy to wear.

The researchers will give participants a head-set so that participants can communicate at all times with the person running the scan.

First participants will have a MRI scan where the researchers ask participants to lie back and relax (this will take about 30 minutes).

Then the researchers will ask participants to exercise on the MRI safe bike for about 7 minutes, lift the weight for about 3 minutes, or perform leg stepping for about 3 minutes whilst participants are having continuous MRI scanning.

After the scan, the researchers will help participants out of the scanner.

What are the possible benefits and risks of participating? There are no individual benefits to taking part. The researchers hope that information from this study will help improve the understanding and treatment of heart conditions that can limit exercise ability. If participants like the researchers can make participants a copy of their scan on CD to keep. Sometimes the researchers might find new information that the researchers need to tell their treating doctor straight away. If the researchers do find such information the researchers will let participants and their doctor know as soon as possible. The researchers will reimburse reasonable travel expenses for participants to attend the research scan (unless participants are already scheduled to have a clinical visit on the same day). MRI scanning is very safe.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: October 1, 2021
• Est. primary completion date: October 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Age 18-80 years

2. Symptoms of breathlessness on exertion under the care of cardiology, pulmonary hypertension or rheumatology clinics for non-ischaemic cardiovascular disease

3. Willing and able to provide written informed consent

Exclusion Criteria:

1. Previous ischaemic heart disease (including angina, myocardial infarction, PCI, CABG)

2. Unstable symptoms (including crescendo angina or angina at rest, and syncope on exercise)*

3. Arrhythmia**

4. Musculoskeletal disease preventing exercise

5. Patients unable to provide consent

6. General contraindications to CMR (e.g. implanted metal objects, pregnancy, severe claustrophobia)

7. Significant parenchymal lung disease (defined as >20% extent parenchymal disease on CT)

8. WHO functional class IV symptoms *Patients with unstable symptoms have been excluded as it would be unsafe for them to perform exercise whilst in a MRI scanner. Patients unable to exercise, WHO functional class IV and those with significant lung disease have been excluded as they would be unable to complete the exercise protocol **The researchers have excluded patients with arrhythmia as this can reduce the reliability of some of the CMR image sequences and also results in less predictable heart rate response to exercise

Related Conditions & MeSH terms

• Hypertension, Pulmonary
• Pulmonary Hypertension

Intervention

Procedure:
• Combined Cardiovascular Magnetic Resonance and Cardiopulmonary Exercise Testing
Clinical Cardiac MRI scan at rest with routine administration of gadolinium contrast agent. Participants then undergo the research component of the test which requires them to perform exercise, using a recumbent, MRI-compatible cycle ergometer, whilst their breathing is simultaneously analysed using a mask connected to a CPET machine, until they are limited by symptoms and they stop pedalling. Most participants will undergo only one scan. Some participants will be asked to have two or three such scans over 3 months to assess changes over time, and in response to standard treatment of pulmonary hypertension.

Locations

Country	Name	City	State
United Kingdom	Royal Free Hospital NHS Foundation Trust	London

Sponsors (3)

Lead Sponsor	Collaborator
Royal Free Hospital NHS Foundation Trust	Actelion, British Heart Foundation

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiac output (L/min) measured using aortic flow from PCMR measurements	Cardiac output (L/min) measured using aortic flow from PCMR measurements measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Ventricular volumes (mL) measured using volumetric measurements of both ventricles, at end-diastole and end-systole	Ventricular volumes (mL) measured using volumetric measurements of both ventricles, at end-diastole and end-systole measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Heart rate (bpm) from MRI ECG/heart rate monitor	Heart rate (bpm) from MRI ECG/heart rate monitor measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Blood pressure (mmHg) from MRI-compatible BP monitor	Blood pressure (mmHg) from MRI-compatible BP monitor measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Oxygen consumption (VO2, mL/min) from CPET machine	Oxygen consumption (VO2, mL/min) from CPET machine measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Carbon dioxide production (VCO2, mL/min) from CPET machine	Carbon dioxide production (VCO2, mL/min) from CPET machine measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Arteriovenous Oxygen Gradient (Muscle oxygen consumption, mlO2/100mL blood/min) calculated from Cardiac Output and VO2	Arteriovenous Oxygen Gradient (Muscle oxygen consumption, mlO2/100mL blood/min) measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise calculated from Cardiac Output and VO2	Change from Baseline at 3 months
Primary	Respiratory exchange ratio (RER) from CPET machine	Respiratory exchange ratio (RER) from CPET machine measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Primary	Exercise duration (sec) measured using a timer from the start to the end of exercise	Exercise duration (sec) measured using a timer from the start to the end of exercise measured at rest, at 2 minutes intervals during exercise, at 2 minutes and 4 minutes after end of exercise	Change from Baseline at 3 months
Secondary	Cardiac Troponin T (ng/L) measured using blood sample prior to scan	Cardiac Troponin T (ng/L) measured using blood sample prior to scan and after scan	through study completion, an average of 1 year
Secondary	N-terminal pro-BNP (ng/L) measured using blood sample prior to scan	N-terminal pro-BNP (ng/L) measured using blood sample prior to scan and after scan	through study completion, an average of 1 year
Secondary	Haemoglobin (g/L) measured using blood sample prior to scan	Haemoglobin (g/L) measured using blood sample prior to scan and after scan	through study completion, an average of 1 year
Secondary	Autoantibody profile measured using blood sample prior to scan	Autoantibody profile measured using blood sample prior to scan and after scan	through study completion, an average of 1 year
Secondary	Invasive pulmonary pressures (PA systolic/diastolic/mean) in MR-RHC substudy measured using a pressure transducer at rest and after 1 min of exercise	Invasive pulmonary pressures (PA systolic/diastolic/mean) in MR-RHC substudy measured using a pressure transducer at rest and after 1 min of exercise	through study completion, an average of 1 year
Secondary	PH disease progression (WHO Functional class) measured using patient records	PH disease progression (WHO Functional class) measured using patient records	Change from baseline at 6 months
Secondary	Mortality measured using patient records	Mortality measured using patient records	Change from baseline at 6 months